Citation Impact
Citing Papers
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
2013
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
2008
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
2009 StandoutScience
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Recognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
2008 StandoutScienceNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
2005
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
2009
Mechanism of All- Trans Retinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor Cells
2007
Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells
2008
Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
2008
Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection
2007 StandoutNobel
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
2008
CD11b+Ly-6Chi Suppressive Monocytes in Experimental Autoimmune Encephalomyelitis
2007
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
The Importance of Myeloid-Derived Suppressor Cells in the Regulation of Autoimmune Effector Cells by a Chronic Contact Eczema
2007
Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Amino-Biphosphonate–Mediated MMP-9 Inhibition Breaks the Tumor-Bone Marrow Axis Responsible for Myeloid-Derived Suppressor Cell Expansion and Macrophage Infiltration in Tumor Stroma
2007
Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells
2005
B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer
2008
Altered macrophage differentiation and immune dysfunction in tumor development
2007
Inflammatory networks and immune surveillance of pancreatic carcinoma
2013
The biology and management of non-small cell lung cancer
2018 StandoutNature
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Imaging in the era of molecular oncology
2008 StandoutNature
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
2006
Regulatory T Cells in Cancer
2010
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The Human T Cell Response to Melanoma Antigens
2006
NRF2 and the Hallmarks of Cancer
2018
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
2006
Control of the Immune Response by Pro-Angiogenic Factors
2014
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease: A New Immunoregulatory Pathway
2008
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
2004
Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice
2007
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
2007
Nonresolving Inflammation
2010 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Pancreatic Adenocarcinoma
2014 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Immune surveillance of tumors
2007
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
2008
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Mechanisms and functional significance of tumour-induced dendritic-cell defects
2004
Immunity, Inflammation, and Cancer
2010 Standout
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
2008
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
2015 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Mechanisms of Immune Evasion by Tumors
2006
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Migratory neighbors and distant invaders: tumor-associated niche cells
2008
Regulation of immune responses by L-arginine metabolism
2005
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Exploring the full spectrum of macrophage activation
2008 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
2011 StandoutNature
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
2007 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
2012
Modulation of the antitumor immune response by complement
2008
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
CD11b+/Gr-1+ Immature Myeloid Cells Mediate Suppression of T Cells in Mice Bearing Tumors of IL-1β-Secreting Cells
2005
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
2008
Development of Monocytes, Macrophages, and Dendritic Cells
2010 StandoutScience
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14+HLA-DRlo/neg Cells): The Gateway to Improved Responses
2014
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
2007
Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer
2006
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
2008
Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells
2009
Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease
2005
Reduced Inflammation in the Tumor Microenvironment Delays the Accumulation of Myeloid-Derived Suppressor Cells and Limits Tumor Progression
2007
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Interleukin-13–regulated M2 Macrophages in Combination with Myeloid Suppressor Cells Block Immune Surveillance against Metastasis
2005
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
2010
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activity
2008
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host
2006
Reactive Oxygen Species and 12/15-Lipoxygenase Contribute to the Antiproliferative Capacity of Alternatively Activated Myeloid Cells Elicited during Helminth Infection
2005
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
2014
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells
2012
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
2006
CSF-1–Dependent Red Pulp Macrophages Regulate CD4 T Cell Responses
2011 StandoutNobel
Inflammation Induces Myeloid-Derived Suppressor Cells that Facilitate Tumor Progression
2006
Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response
2007
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
2007
Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T‐cell responses
2008
Immunosuppressive Strategies that are Mediated by Tumor Cells
2006
STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion
2005
Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo
2005
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
2008
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
2010 StandoutNobel
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
2005
Blockade of Myeloid-Derived Suppressor Cells after Induction of Lymphopenia Improves Adoptive T Cell Therapy in a Murine Model of Melanoma
2012
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
2006
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Mycobacteria-induced Gr-1+ subsets from distinct myeloid lineages have opposite effects on T cell expansion
2007
Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4
2009
B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma
2006
Works of Daniel Yoder being referenced
Pharmacokinetics and Imaging of 212 Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients
2013
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
2004